PR

Prabhat Ranjan Yadav

Active Director Director DIN 07506386
DIN 07506386 First appointment May 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Prabhat Ranjan Yadav

Data last updated:

Prabhat Ranjan Yadav is a Director at Renexy Life Sciences Private Limited (since 2016). The company operates in Business Services.

DIN 07506386
Primary Designation Director
Industry Business Services
First Appointment 20 May 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Renexy Life Sciences Private Limited U74999MH2016PTC281355
Director20 May 20162016Active

Board colleagues of Prabhat Ranjan Yadav

Directorship timeline

Open interactive timeline →
Renexy Life Sciences Private Limited
Premium access

Shareholding and investment profile for Prabhat Ranjan Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prabhat Ranjan Yadav

Prabhat Ranjan Yadav currently holds 1 directorship: Renexy Life Sciences Private Limited (Director, since 20 May 2016).

Prabhat Ranjan Yadav was first appointed on 20 May 2016 as Director at Renexy Life Sciences Private Limited.

The current boards of Prabhat Ranjan Yadav's companies include Motilal Bind (Renexy Life Sciences Private Limited), Pradeep Kumar (Renexy Life Sciences Private Limited), Renu Yadav (Renexy Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available